This HTML5 document contains 132 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n12http://dx.doi.org/10.4103/

Statements

Subject Item
wd:Q41762226
rdf:type
wikibase:Item
schema:description
tieteellinen artikkeli articol științific artikel ilmiah 2011年论文 artículo científico publicado en 2011 artikulong pang-agham vetenskaplig artikel artigo científico 2011年论文 bilimsel makale επιστημονικό άρθρο naučni članak научная статья מאמר מדעי scientific article published on May 2011 vedecký článok wetenschappelijk artikel مقالة علمية نشرت في مايو 2011 tudományos cikk 2011年論文 wissenschaftlicher Artikel bài báo khoa học artykuł naukowy 2011年论文 artículu científicu espublizáu en 2011 articolo scientifico 2011年論文 2011年论文 2011 nî lūn-bûn artikull shkencor article scientific научни чланак scienca artikolo научни чланак บทความทางวิทยาศาสตร์ artigo científico научна статия vitenskapelig artikkel scientific article published on May 2011 2011年論文 2011年论文 teaduslik artikkel মে ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2011年論文 article científic artigo científico videnskabelig artikel vitskapeleg artikkel 2011年论文 наукова стаття, опублікована в травні 2011 мақолаи илмӣ 2011년 논문 2011年論文 scientific article published on May 2011 vědecký článek article scientifique სამეცნიერო სტატია 2011年の論文
p:P577
wds:Q41762226-871777C8-9CE1-4077-A5D5-1F0E374E0BB5
wdt:P577
2011-05-01T00:00:00Z
p:P407
wds:Q41762226-4843483B-2A11-4503-B410-8B75319A595B
wdt:P407
wd:Q1860
p:P2860
wds:Q41762226-0F971D7E-011E-4A98-99F2-FB2F36704633 wds:Q41762226-1BCB4A18-CBDA-401D-9C80-E4BB8BF7E298 wds:Q41762226-3AD4A8D2-8B4B-48F4-9A59-CA668F67BF90 wds:Q41762226-3ECCDDF3-1FCA-48A9-85BB-50FD8D1B59BF wds:Q41762226-443FCB5F-6E89-437A-9580-B53C0D5761A5 wds:Q41762226-5612F55E-933E-49B1-B459-E507068F4E4F wds:Q41762226-8F86BF42-AA87-4FDA-AD99-34D61AD82471 wds:Q41762226-A643F0FB-C85D-4DFD-BB03-0A5FF5D038F8 wds:Q41762226-C054A7D0-5DE6-4D88-A125-33BBE23D90E3 wds:Q41762226-C8FA7771-BC0E-4296-9A8D-70097EF378EB wds:Q41762226-D6B6CE24-E343-4F5D-8E4D-36908C87486F
wdt:P2860
wd:Q35763017 wd:Q73109816 wd:Q46683851 wd:Q42840729 wd:Q46872603 wd:Q44516142 wd:Q44399938 wd:Q35763028 wd:Q46266239 wd:Q57652449 wd:Q35762959
p:P2093
wds:Q41762226-7844F88D-A960-4710-B2AC-5A8F26EE4FAA wds:Q41762226-4D0ECA17-E0A6-4CC4-B3E8-ECF04CFBC822 wds:Q41762226-CDD9C0F2-9096-43FE-85C7-8DEDAE2010A4 wds:Q41762226-89B59D14-CDE6-46AD-99A8-F3C848400AC8 wds:Q41762226-1527F7B7-A91D-420B-86F5-B8E7FEA2A156 wds:Q41762226-4C2740AD-EB30-47A6-96CC-7B209B5131F9 wds:Q41762226-3571937E-28AF-4D57-B2EA-D92A2D16374A wds:Q41762226-38975A43-2BBC-4AC6-81CB-E81F37E00EED
wdt:P2093
Ekta Rishi Dhanashree Ratra Parveen Sen Tarun Sharma Muna Bhende Pratik Ranjan Sen Anusha Venkataraman Lingam Gopal
rdfs:label
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
skos:prefLabel
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
schema:name
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
p:P50
wds:Q41762226-E278E239-78A6-492A-926A-C66C2A6DC429
wdt:P50
wd:Q57335563
p:P1476
wds:Q41762226-72EE1368-A143-416F-BE88-110A2055331D
wdt:P1476
Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
p:P304
wds:Q41762226-14AAF0B4-2DB5-43A7-A0B3-E8AA35A3817E
wdt:P304
242-246
p:P31
wds:Q41762226-266FA856-9F57-408F-8500-95D732F78357
wdt:P31
wd:Q13442814
p:P921
wds:Q41762226-43E9705C-379E-4095-8288-FA4A28BF30AB wds:Q41762226-C234E696-D74E-43DF-824B-AA439F8368B4 wds:Q41762226-67593138-A4B8-40B0-9E58-5A63562E5C26
wdt:P921
wd:Q413299 wd:Q1281049 wd:Q168403
p:P698
wds:Q41762226-E89DDDDF-D9D0-4CFC-9310-CEAC184CEB4F
wdtn:P698
n11:21586852
wdt:P698
21586852
p:P1433
wds:Q41762226-6BDD7FF7-E2FF-4A1B-8665-19405748C76E
wdt:P1433
wd:Q6020800
p:P433
wds:Q41762226-1B94952C-FB4B-4F85-9C55-D0774351BD4E
p:P478
wds:Q41762226-9C2085E2-0075-4C3F-AD79-E79BFD365669
wdt:P433
3
wdt:P478
59
p:P356
wds:Q41762226-13C4189F-E120-4F97-9E61-15BDC0ED5443
wdtn:P356
n12:0301-4738.81049
wdt:P356
10.4103/0301-4738.81049
p:P932
wds:Q41762226-6091DF66-EA4A-4DDB-8F6F-F23BBDEE7F53
wdt:P932
3120250